Importantly, the overall 5-year survival rate was significantly higher in patients receiving triweekly cisplatin compared with the weekly regimen (88.7% versus 66.5%).

Background: Concurrent chemoradiotherapy (CCRT) with cisplatin (CDDP) is a standard treatment for locally advanced head and neck cancer (LAHNC) in the definitive setting. Three cycles of 100 mg/m 2 ...

Background: In 2002, due to the significant toxicities associated with triweekly high-dose cisplatin, we decided to routinely use triweekly carboplatin in the treatment of locally advanced head and ...

Biweekly, triweekly flights favoured Updated - February 12, 2016 05:40 am IST - Mysuru: R. Krishna Kumar READ LATER ...